Specifically, thrombosis occurrence was not available in this cohort, and we note that circulating CD34-positive cell quantification may also be of interest for assessing thrombotic risk, given the potential link between increased progenitor cell mobilization and vascular complications. This evidence concerns the gene CD34 and deep vein thrombosis.